The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.

In essence, the future of AI is inextricably linked to advancements in data management, making it an indispensable enabler of ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

AI-powered tools like Merck’s Aiddison can accelerate drug identification and optimise design, cutting both costs and time to ...

(TSX-V: RKV)(FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI ...

Maharashtra plans to introduce drug testing kits for drivers as road accidents claim over 40 lives daily. The state will ...

Modern AI technology is data-hungry. In many areas, data is scarce. For example, in our work in early oncology clinical trials, we only have data on about 20 patients, so we tend to use theory-based ...

Molecular Devices' CellXpress AI streamlines cell culture processes, reducing human error and improving efficiency in drug ...

Then they test these compounds on animals during preclinical ... have released similar documents on the use of AI in drug development processes. But the FDA guidelines are notable because they ...

Technology Networks caught up with Hartung after the event to discuss his insights on the future of drug testing, the role of AI in toxicology and the regulatory and ethical challenges in moving away ...

Artificial intelligence (AI) is emerging as a tool that can improve patient outcomes and provider care efficiency, says Douglas Flora, MD, FACCC, of St. Elizabeth Healthcare.

Canada has a clear opportunity to use its deep scientific and research capabilities to transform its innovation system to be ...